title: Letter by Metzler et al regarding article, "Intracoronary KAI-9803 as an adjunct to primary coronary intervention for acute ST-segment elevation myocardial infarction".
authors.forename: Bernhard
authors.initials: B
authors.lastname: Metzler
authors.forename: Qingbo
authors.initials: Q
authors.lastname: Xu
authors.forename: Manuel
authors.initials: M
authors.lastname: Mayr
mesh_terms: D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010455:Peptides / Q000009:adverse effects*; D051745:Protein Kinase C-delta / Q000502:physiology*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects
chemical_list: C527142:KAI 9803; D010455:Peptides; D047428:Protein Kinase Inhibitors; D051745:Protein Kinase C-delta